Page last updated: 2024-10-29

indoprofen and Biliary Tract Diseases

indoprofen has been researched along with Biliary Tract Diseases in 1 studies

Indoprofen: A drug that has analgesic and anti-inflammatory properties. Following reports of adverse reactions including reports of carcinogenicity in animal studies it was withdrawn from the market worldwide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p21)
indoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(1-oxo-1,3-dihydroisoindol-2-yl)phenyl group. Initially used as an anti-inflammatory and analgesic, it was withdrawn from the market due to causing severe gastrointestinal bleeding. It has been subsequently found to increase production of the survival motor neuron protein.

Biliary Tract Diseases: Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sacchetti, G1

Trials

1 trial available for indoprofen and Biliary Tract Diseases

ArticleYear
Indoprofen analgesia for biliary pain.
    Lancet (London, England), 1979, Aug-25, Volume: 2, Issue:8139

    Topics: Biliary Tract Diseases; Clinical Trials as Topic; Colic; Double-Blind Method; Drug Evaluation; Human

1979